Dark

KPTI
Karyopharm Therapeutics Inc.
stock NASDAQ

At Close

Feb 12, 2026 3:59:59 PM EST

9.00USD+22.117%(+1.63)2,749,910

9.09Bid 9.15Ask 0.06Spread

Pre-market

Feb 12, 2026 9:28:30 AM EST

6.75USD-8.412%(-0.62)18,128

After-hours

Feb 12, 2026 4:57:30 PM EST

9.65USD+7.222%(+0.65)3,064

OverviewOptionsHistoricalExchangesShortsMore

open chart

Market Cap

164.61M

CEO

Michael Kauffman

Headquarters

Newton Center, Massachusetts, USA

Industry

Biotechnology

Next Earnings

Feb 12, 2026 (today)

Last Split

Feb 26, 20251for15reverse

IMMU EXEL ECYT ABT BMY MRK XLV

KPTI Stats

Avg. Vol. 10 Day

406,645

Avg. Vol. 30 Day

442,211

Employees

154

Market Cap

164,609,444

Shares Out.

18,310,283

On/Off Exchange

47%/53%

6 Month Beta

1.71

1 Year Beta

1.09

2 Year Beta

0.93

3 Year Beta

1.14

52 Week Low

3.51

52 Week High

10.38

SMA50

6.78

SMA200

5.75

1 Week

+47.62%

1 Month

+9.70%

3 Month

+60.82%

6 Month

+123.63%

1 Year

+2.31%

2 Year

-53.90%

5 Year

-96.06%

Profile

karyopharm therapeutics inc. is a clinical-stage pharmaceutical company focused on discovery and development of novel first-in-class drugs directed against nuclear transport targets for the treatment of cancer and other major diseases. for more information, please visit www.karyopharm.com

KPTI Stock Summary

Karyopharm Therapeutics Inc. (NASDAQ:KPTI) stock price today is $9.00, and today's volume is 2,749,910. KPTI is up 22.117% today. The 30 day average volume is 442,211. KPTI market cap is 164.61M with 18,310,283 shares outstanding.

.dark-mode .csgjcq{ color: white; background-color: #333333; border: 2px solid white; }.light-mode .csgjcq{ color: #333333; background-color: white; border: 2px solid #333333; }KPTIKaryopharm Therapeutics Inc.stock NASDAQ

KPTI Stock Summary

KPTI
Karyopharm Therapeutics Inc.
stock NASDAQ